Partial nephrectomy versus ablative therapies for cT1a renal masses: A Systematic Review and meta-analysis

ConclusionCompared to PN, ablation may have a significantly lower OS and higher local recurrence rates in selected patients, while CSS and DFS were comparable between the two treatments. On the other hand, ablation had a significantly decreased risk of perioperative complication and the potential advantage of long-term renal function preservation. More large randomized controlled trials are needed further to enhance the evidence of ablation in patients with small renal tumors. We believe that ablation is an attractive addition to the urologist's treatment options for small renal masses.
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research